Ignite Creation Date:
2024-05-06 @ 1:34 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04060862
Status:
TERMINATED
Last Update Posted:
2024-04-03
First Post:
2019-08-13
Brief Title:
A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-13
First Submit QC Date:
August 15 2019
Study First Post Date:
2019-08-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-02
Last Update Post Date:
2024-04-03
Last Update Post Date Type:
ACTUAL